$KPRX News
Last published 5h ago
- 5h agoKPRXKIORA PHARMACEUTICALS INC - EX-99.1Earnings ReleasesForm 8-K - Current report - Item 2.02 Item 9.01
- 1y agoKPRXKiora Pharmaceuticals Joins RARE-X Vision Consortium Promoting Collaboration and Development of New Treatments for Rare Ocular DisordersPR NewswireKiora Pharmaceuticals, Inc. (NASDAQ: KPRX) and Global Genes today announced that Kiora has joined Global Genes' RARE-X Vision Consortium, a...
- 1y agoKPRXRBOTVicarious Surgical Announces Leadership Transition: Stephen From, Healthcare Industry Veteran, Appointed Chief Executive OfficerBusiness WireAdam Sachs, Co-Founder, to Remain on as President Vicarious Surgical Inc. (NYSE:RBOT, RBOT WS)) (the "Company"), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery,
- 3y agoKPRXGroundbreaking clinical trial underway to improve vision in individuals with advanced Retinitis Pigmentosa (RP)PR NewswirePutting Australian clinical research on the map globally, comes the ground-breaking first-in-human clinical trial for KIO-301. MELBOURNE, Australia, Feb. 14, 2023 /PRNewswire/ -- In collaboration with US-based Kiora
- 4y agoDNAYFTKKPRXNAKD+1Thinking about buying stock in Kiora Pharmaceuticals, Tencent Music Entertainment, Naked Brand, Flotek Industries, or Codex DNA?PR NewswireNEW YORK, Dec. 31, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for KPRX, TME, NAKD, FTK, and DNAY. T
- 4y agoARDSBVXVKPRXNAKD+1Thinking about buying stock in Reliance Global, Naked Brand, Kiora Pharmaceuticals, Aridis Pharmaceuticals, or Biondvax Pharmaceuticals?PR NewswireNEW YORK, Dec. 30, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for RELI, NAKD, KPRX, ARDS, and BVXV.
- 4y agoKPRXKiora Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Business UpdateGlobeNewswireSALT LAKE CITY, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX), ("Kiora" or the "Company") today reported its financial results for the quarter ended September 30, 2021 and provided an update on recent corporate and operati
- 5y agoEYEGKPRXEyeGate is Now Kiora Pharmaceuticals; Provides Update on Company's Sharpened Clinical Development StrategyGlobeNewswireSALT LAKE CITY, Nov. 08, 2021 (GLOBE NEWSWIRE) -- Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX), ("Kiora" or the "Company") is the new name of EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG). Kiora will trade on the Nasdaq Capital Market under the ticker symbo